IL18 and Alzheimer disease: Interleukin-1β and IL-18 can regulate or participate in neuronal damage through different mechanisms in the blood–brain barrier or in brain before or during AD occurred including in the brain and the periphery (Heppner et al., 2015; He et al., 2016; Heneka et al., 2018).